Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00201266 · ClinicalTrials.gov registry record
Histoblood Group Antigens as a Risk Factor of Asthma
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 126
- Enrollment target
NCT00201266: Completed study, sponsored by University of California, San Francisco.
NCT00201266 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00201266 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
This study will evaluate the link between blood group antigens and asthma exacerbations.
Interventions
- PROCEDURE Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2005-07 |
| Est. Completion | 2013-08 |
What the finished NCT00201266 record still lists
NCT00201266 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Screening is the first listed.
NCT00201266 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00201266 about?
NCT00201266 is a clinical study titled "Histoblood Group Antigens as a Risk Factor of Asthma". This study will evaluate the link between blood group antigens and asthma exacerbations.
What is the current status of trial NCT00201266?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2005-07. Estimated completion is 2013-08.
What interventions are being tested in trial NCT00201266?
The interventions under investigation include: Screening (PROCEDURE).
Who is sponsoring clinical trial NCT00201266?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia